About this trial

Development of preclinical translational models for chronic liver tumors and diseases study, such as spheroids cultured in autologous medium and murine xenograft models to test the efficacy of new therapeutic strategies.

Eligibility criteria

Qualifiers

Patients

diagnosed with chronic liver disease (viral or not)

diagnosed with at least one liver nodule for which a biopsy is planned as part of the care

for hepatobiliary surgery planned as part of care

Disqualifiers

Minor patients

Patients under legal protection,

Patients subject to legal protection or unable to express their consent,

Patients in a situation of social fragility,

Trial design

Treatments tested in this trial

  • Blood sample during surgery
  • Taking an additional biopsy
  • Blood sample during diagnostic test

Treatment groups

800 Participants
are divided into 3 treatment groups

Locations

1
PU-PH, Directeur de l'UMR_S1110 Unité Inserm d'affiliation : UMR_S111067000, Strasbourg France

Sponsors and collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Lead sponsor